High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B

Table 1

Demographic and clinical characteristics of the patients.

	Number	Range
Age	40	27–79 years; Mean 54 years; ± SD 8.94
Gender	40	Male 32 (80%); Female 8 (20%)
HBSAg	40	40 positive (100%)
HBSAb	40	32 positive (80%); 8 negative (20%)
HBeAg	40	25 positive (62.5%); 15 negative (37.5%)
HBeAb	40	15 positive (37.5%); 25 negative (62.5%)